Incannex (IXHL) Healthcare announced the completion of a $16.7M gross proceeds capital raise through its at-the-market facility. $12.5M of these proceeds will be used to cancel up to 50.4% of the Series A Warrants previously issued as part of a prior financing agreement. This strategic initiative significantly reduces potential future dilution attributable to the Series A Warrants, with up to 5,841,038 of these warrants eligible for cancellation. If triggered, the adjustment features of these Series A Warrants could otherwise have resulted in up to 175.2M additional shares being issued. This move underscores Incannex’s proactive approach to capitalization management and shareholder alignment.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IXHL:
- Incannex announces potential reduction of Series A warrants
- Incannex Healthcare Announces Warrant Reduction Strategy
- VA secretary wants to find answers on psychedelics therapies, Politico says
- Incannex Healthcare Adjusts Series A Warrants Agreement
- Psychedelic: Atai, Enveric, Incannex and Relmada report quarterly results